![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Pfizer |
---|---|
Information provided by: | NIH AIDS Clinical Trials Information Service |
ClinicalTrials.gov Identifier: | NCT00002090 |
To evaluate the efficacy and safety of two doses of azithromycin given chronically for the treatment of Mycobacterium avium bacteremia in AIDS patients.
Condition | Intervention |
---|---|
Mycobacterium Avium-Intracellulare Infection HIV Infections |
Drug: Azithromycin |
Study Type: | Interventional |
Study Design: | Treatment, Dose Comparison, Safety Study |
Official Title: | An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS) |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria
Concurrent Medication:
Allowed:
Patients must have:
Exclusion Criteria
Co-existing Condition:
Patients with the following symptoms and conditions are excluded:
Prior Medication:
Excluded:
Not expected to comply with the requirements of the protocol, in the opinion of the investigator.
United States, Massachusetts | |
Beth Israel Hosp | |
Boston, Massachusetts, United States, 02215 | |
United States, New York | |
SUNY / Health Sciences Ctr at Syracuse | |
Syracuse, New York, United States, 13210 | |
Bronx Veterans Affairs Med Ctr | |
Bronx, New York, United States, 10468 | |
United States, Ohio | |
Ohio State Univ Hosp | |
Columbus, Ohio, United States, 43210 | |
United States, Texas | |
United States Air Force Med Ctr | |
Lackland Air Force Base, Texas, United States, 78236 | |
Audie L Murphy Veterans Administration Hosp | |
San Antonio, Texas, United States, 78284 |
Study ID Numbers: | 058H, 066-148 |
Study First Received: | November 2, 1999 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00002090 |
Health Authority: | United States: Food and Drug Administration |
Mycobacterium avium-intracellulare Infection Acquired Immunodeficiency Syndrome Azithromycin |
Bacterial Infections Sexually Transmitted Diseases, Viral Acquired Immunodeficiency Syndrome Immunologic Deficiency Syndromes Mycobacterium Infections, Atypical Mycobacterium avium-intracellulare Infection Virus Diseases |
Gram-Positive Bacterial Infections HIV Infections Azithromycin Sexually Transmitted Diseases Mycobacterium Infections Mycobacterium avium complex infection Retroviridae Infections |
Communicable Diseases Anti-Infective Agents RNA Virus Infections Slow Virus Diseases Disease Immune System Diseases Infection |
Pharmacologic Actions Actinomycetales Infections Anti-Bacterial Agents Pathologic Processes Syndrome Therapeutic Uses Lentivirus Infections |